Development of a Nomogram to Predict the Risk of 30-Day Re-Exacerbation for Patients Hospitalized for Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Global Health Estimates. 2016: Disease burden by cause, age, sex, by country and by region, 2000–2016. Geneva: World Health Organization; 2018.
   Google Scholar
• Global Health Estimates. 2016: Deaths by cause, age, sex, by country and by region, 2000–2016. Geneva: World Health Organization; 2018.
   Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002; 57(10): 847–852. doi: 10.1136/thorax.57.10.847.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998; 157(5 Pt 1): 1418–1422. doi: 10.1164/ajrccm.157.5.9709032.
   PubMed Web of Science ®Google Scholar
• Mullerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015; 147(4): 999–1007. doi: 10.1378/chest.14-0655.
   PubMed Web of Science ®Google Scholar
• Price LC, Lowe D, Hosker HS, Anstey K, Pearson MG, Roberts CM, British Thoracic S, the Royal College of Physicians Clinical Effectiveness Evaluation U. UK National COPD Audit 2003: Impact of hospital resources and organisation of care on patient outcome following admission for acute COPD exacerbation. Thorax. 2006; 61(10): 837–842. doi: 10.1136/thx.2005.049940.
   PubMed Web of Science ®Google Scholar
• Make BJ, Eriksson G, Calverley PM, Jenkins CR, Postma DS, Peterson S, Ostlund O, Anzueto A. A score to predict short-term risk of COPD exacerbations (SCOPEX). Int J Chron Obstruct Pulmon Dis. 2015; 10: 201–209. doi: 10.2147/COPD.S69589.
   PubMed Web of Science ®Google Scholar
• Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM, Estudi del Factors de Risc d'Aguditzacio de la Mi. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003; 58(2): 100–105. doi: 10.1136/thorax.58.2.100.
   PubMed Web of Science ®Google Scholar
• Lee SD, Huang MS, Kang J, Lin CH, Park MJ, Oh YM, Kwon N, Jones PW, Sajkov D, Investigators of the Predictive Ability of CATiAEoCS. The COPD assessment test (CAT) assists prediction of COPD exacerbations in high-risk patients. Respir Med. 2014; 108(4): 600–608. doi: 10.1016/j.rmed.2013.12.014.
   PubMed Web of Science ®Google Scholar
• Baker CL, Zou KH, Su J. Risk assessment of readmissions following an initial COPD-related hospitalization. Int J Chron Obstruct Pulmon Dis. 2013;8:551–559.
   PubMed Web of Science ®Google Scholar
• Lin J, Xu Y, Wu X, Chen M, Lin L, Gong L, Feng J. Risk factors associated with chronic obstructive pulmonary disease early readmission. Curr Med Res Opin. 2014; 30(2): 315–320. doi: 10.1185/03007995.2013.858623.
   PubMed Web of Science ®Google Scholar
• Liu D, Peng SH, Zhang J, Bai SH, Liu HX, Qu JM. Prediction of short term re-exacerbation in patients with acute exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015; 10: 1265–1273. doi: 10.2147/COPD.S83378.
   PubMed Web of Science ®Google Scholar
• Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Criner GJ, Kim V, Bowler RP, Hanania NA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011; 261(1): 274–282. doi: 10.1148/radiol.11110173.
   PubMed Web of Science ®Google Scholar
• Almagro P, Soriano JB, Cabrera FJ, Boixeda R, Alonso-Ortiz MB, Barreiro B, Diez-Manglano J, Murio C, Heredia JL, Working Group on Copd SoIM. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest. 2014; 145(5): 972–980. doi: 10.1378/chest.13-1328.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013; 31(9): 1188–1195. doi: 10.1200/JCO.2012.41.5984.
   PubMed Web of Science ®Google Scholar
• Sakamoto Y, Yamauchi Y, Yasunaga H, Takeshima H, Hasegawa W, Jo T, Sasabuchi Y, Matsui H, Fushimi K, Nagase T. Development of a nomogram for predicting in-hospital mortality of patients with exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2017; 12: 1605–1611. doi: 10.2147/COPD.S129714.
   PubMed Web of Science ®Google Scholar
• Niewoehner DE, Lokhnygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K, Kesten S. Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007; 131(1): 20–28. doi: 10.1378/chest.06-1316.
   PubMed Web of Science ®Google Scholar
• Mahler DA, Harver A. A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992;145(2 Pt 1):467–470. doi: 10.1164/ajrccm/145.2_Pt_1.467.
   PubMed Web of Science ®Google Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009; 34(3): 648–654. doi: 10.1183/09031936.00102509.
   PubMed Web of Science ®Google Scholar
• Global Strategy for the Diagnosis, Management and Prevention of COPD-2017 [Internet]. Global Initiative for Chronic Obstructive Pulmonary Disease; [cited 2018 Aug]. Available from: https://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/.
   Google Scholar
• Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(5): 1608–1613. doi: 10.1164/ajrccm.161.5.9908022.
   PubMed Web of Science ®Google Scholar
• Posada D, Buckley TR. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol. 2004;53(5):793–808. doi: 10.1080/10635150490522304.
   PubMed Web of Science ®Google Scholar
• Wagenmakers EJ, Farrell S. AIC model selection using Akaike weights. Psychon Bull Rev. 2004;11:192–196.
   PubMed Web of Science ®Google Scholar
• Rms: Regression modeling strategies. R package version 5.0–0. 2016 [Internet]. Harrell Jr FE; [cited 2018 Aug]. Available from: http://CRAN.R-project.org/ package = rms.
   Google Scholar
• Jacobs DM, Noyes K, Zhao J, Gibson W, Murphy TF, Sethi S, Ochs-Balcom HM. Early Hospital Readmissions after an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the Nationwide Readmissions Database. Ann Am Thorac Soc. 2018; 15(7): 837–845. doi: 10.1513/AnnalsATS.201712-913OC.
   PubMed Web of Science ®Google Scholar
• Kocher RP, Adashi EY. Hospital readmissions and the Affordable Care Act: paying for coordinated quality care. JAMA. 2011;306(16):1794–1795. doi: 10.1001/jama.2011.1561.
   PubMed Web of Science ®Google Scholar
• Steer J, Norman EM, Afolabi OA, Gibson GJ, Bourke SC. Dyspnoea severity and pneumonia as predictors of in-hospital mortality and early readmission in acute exacerbations of COPD. Thorax. 2012; 67(2): 117–121. doi: 10.1136/thoraxjnl-2011-200332.
   PubMed Web of Science ®Google Scholar
• Hartl S, Lopez-Campos JL, Pozo-Rodriguez F, Castro-Acosta A, Studnicka M, Kaiser B, Roberts CM. Risk of death and readmission of hospital-admitted COPD exacerbations: European COPD Audit. Eur Respir J. 2016; 47(1): 113–121. doi: 10.1183/13993003.01391-2014.
   PubMed Web of Science ®Google Scholar
• García-Rivero JL, Esquinas C, Barrecheguren M, Bonnin-Vilaplana M, García-Sidro P, Herrejón A, Martinez-Rivera C, Molina RM, Marcos PJ, Mayoralas S, et al. Risk factors of poor outcomes after admission for a COPD exacerbation: multivariate logistic predictive models. COPD. 2017;14(2): 164–169. doi: 10.1080/15412555.2016.1260538.
   PubMedGoogle Scholar
• García-Sidro P, Naval E, Rivera CM, Bonnin-Vilaplana M, Garcia-Rivero JL, Herrejon A, Molina RM, Marcos PJ, Mayoralas-Alises S, Ros JA, et al. The CAT (COPD Assessment Test) questionnaire as a predictor of the evolution of severe COPD exacerbations. Respir Med. 2015;109(12): 1546–1552. doi: 10.1016/j.rmed.2015.10.011.
   PubMed Web of Science ®Google Scholar
• Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970–976. doi: 10.1136/thoraxjnl-2012-202103.
   PubMed Web of Science ®Google Scholar
• Boudestein LC, Rutten FH, Cramer MJ, Lammers JW, Hoes AW. The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail. 2009; 11(12): 1182–1188. doi: 10.1093/eurjhf/hfp148.
   PubMed Web of Science ®Google Scholar
• Echevarria C, Steer J, Heslop-Marshall K, Stenton SC, Hickey PM, Hughes R, Wijesinghe M, Harrison RN, Steen N, Simpson AJ, et al. The PEARL score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPD. Thorax. 2017; 72(8): 686–693. doi: 10.1136/thoraxjnl-2016-209298.
   PubMed Web of Science ®Google Scholar
• Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM, Jr., Musher DM, Niederman MS, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007; 44 Suppl 2: S27–S72. doi: 10.1086/511159.
   PubMed Web of Science ®Google Scholar